0001477932-24-003315.txt : 20240528 0001477932-24-003315.hdr.sgml : 20240528 20240528060055 ACCESSION NUMBER: 0001477932-24-003315 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240426 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240528 DATE AS OF CHANGE: 20240528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cosmos Health Inc. CENTRAL INDEX KEY: 0001474167 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 270611758 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41308 FILM NUMBER: 24986134 BUSINESS ADDRESS: STREET 1: 5 AGIOU GEORGIOU, PILEA CITY: THESSALONIKI STATE: J3 ZIP: 55438 BUSINESS PHONE: 312-536-3102 MAIL ADDRESS: STREET 1: 5 AGIOU GEORGIOU, PILEA CITY: THESSALONIKI STATE: J3 ZIP: 55438 FORMER COMPANY: FORMER CONFORMED NAME: Cosmos Holdings Inc. DATE OF NAME CHANGE: 20140106 FORMER COMPANY: FORMER CONFORMED NAME: PRIME ESTATES & DEVELOPMENTS INC DATE OF NAME CHANGE: 20091008 8-K/A 1 cosm_8ka.htm FORM 8-K/A cosm_8ka.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

 (AMENDMENT NO. 3)

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) April 26, 2024

 

Cosmos Health Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-54436

 

27-0611758

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

141 West Jackson Blvd, Suite 4236,

Chicago, Illinois

 

60604

(Address of principal executive offices) 

 

(Zip Code)

 

Registrant’s telephone number, including area code (312) 865-0026

 

N/A

(Former name or former address, if changed since last report.)

 

Title of Each Class

 

Trading Symbol

 

Name of Each Exchange

On Which Registered

Common Stock, $.001 par value

 

COSM

 

Nasdaq Capital Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

EXPLANATORY NOTE

 

On April 26, 2024, Cosmos Health Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) to report the dismissal of KPMG Certified Auditors S.A. (“KPMG”) as the Company’s independent registered public accounting firm, effective immediately, and related matters under Item 4.01 of Form 8-K. On May 2, 2024, the Company filed an Amendment on Form 8-K/A (“Amendment No. 1”) to amend the Original Report to include disclosure regarding the appointment of new independent registered auditors of the Company, as required under Item 4.01(b), and to file Exhibit 16.1, Letter from KPMG to the SEC and Exhibit 16.2, Response Letter from Cosmos Health Inc. to KPMG. On May 3, 2024, the Company amended the Original Report by filing a second Amendment on Form 8-K/A (“Amendment No. 2”) regarding the disclosures about the appointment of new independent registered auditors of the Company under Item 4.01(b).

 

The Company hereby amends the Original Report by filing this Amendment on Form 8-K/A (“Amendment No. 3”) to further update the disclosures about the appointment of new independent registered auditors of the Company under Item 4.01(b).

 

Item 4.01 of the Original Report is amended and restated in its entirety as set forth below.

 

Additionally, a new event under Item 3.01 is also being reported in the present Amendment No. 3.

 

Except as set forth herein, no other modifications have been made to the Original Report.

 

ITEM 3.01. NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD; TRANSFER OF LISTING.

 

On May 24, 2024, the Company announced that on May 21, 2024, the Company received a written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rules because the Company has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Quarterly Report”) and the Company also remains delinquent in filing its Annual Report on Form 10-K for the year ended December 31, 2023 (the “Initial Delinquent Filing”).

 

Specifically, Nasdaq Listing Rule 5810(b) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.

 

In accordance with the Nasdaq notification letter received on April 17, 2024, the Company has until June 17, 2024 to submit a plan to regain compliance with respect to the above referenced delinquent reports. Any exception granted by the Nasdaq staff to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or October 14, 2024. If Nasdaq does not accept the Company’s Plan, the Company will have the opportunity to appeal that decision to a Hearings Panel.

 

The April 17, 2024 and May 21, 2024 Nasdaq letters have no immediate effect on the listing of the Company’s shares.

 

The Company is continuing working diligently to complete and file the Annual Report and the Quarterly Report in order to regain compliance with the Nasdaq Listing Rules.

 

The press release announcing the matters described above is attached hereto as Exhibit 99.1 and incorporated herein by reference.

  

 
2

 

  

ITEM 4.01. CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT

 

(a) Dismissal of Previous Independent Registered Public Accounting Firm

 

On April 26, 2024, the Company dismissed KPMG as the Company’s independent registered accountant, effective immediately. The Company’s Audit Committee, mindful of certain filing deadlines under the US securities laws, unanimously voted in favor to dismiss KPMG as the Company’s independent auditors. KPMG was unable to complete the audit of the Company’s financial statements for the year ended December 31, 2023 on a timely basis. The Company’s Board of Directors agreed with such recommendation.

 

KPMG had previously been appointed on August 7, 2023 as the Company’s independent registered public accounting firm with the engagement of the review of the Company’s Third Quarter Form 10-Q and the audit of the Company’s consolidated financial statements as of and for the fiscal year ended December 31, 2023. As previously disclosed, during the two most recent fiscal years and through August 7, 2023, the Company had not consulted with KPMG regarding any matter that was the subject of a disagreement or a reportable event described in Items 304(a)(1)(iv) or (v), respectively, of Regulation S-K under the Securities Exchange Act of 1934.

 

During the subsequent interim period from August 7, 2023 through April 25, 2024, the Company is of the opinion that: there were no (a) disagreements with KPMG on any matter of accounting principles or practices, financial statement disclosures, or auditing scope or procedure, which disagreements, if not resolved to KPMG’s satisfaction, would have caused KPMG to make reference to the subject matter thereof in connection with its report for such period; or (b) reportable events, as described under Item 304(a)(1)(v) of Regulation S-K.

 

We furnished a copy of the disclosures in this report to KPMG and had requested that KPMG furnish us with a letter addressed to the SEC stating whether such firm agrees with the statements made by the Company in response to this Item 4.01, if not, stating the respects in which it does not agree. A copy of the letter was filed as Exhibit 16.1 to Amendment No. 1.

 

In their letter, KPMG has the contrary opinion that there have been disagreements, between KPMG and the Company, on matters of accounting principles or practices, financial statement disclosures, or auditing scope or procedure, and, more specifically, that KPMG has identified certain transactions with a third party consignment vendor that suggested that an illegal act may have occurred and asked the Company’s Audit Committee to undertake a prompt investigation and to facilitate additional audit procedures, that the request was reiterated multiple times and that, at the time of their dismissal, they were not aware of an investigation having been initiated and the additional audit procedures had not been performed.

 

 
3

 

 

The Company objected to such statements made by KPMG and provided a response letter, which was filed as Exhibit 16.2 to the Amendment No. 1. Contrary to KMPG’s assertions, KPMG never informed the Company’s Audit Committee that “an illegal act may have occurred”. Instead, KPMG’s comments consistently referred to concerns over an inventory account and the related transactions between the Company and the third-party vendor. As soon as the issue was raised with the Chairman of the Company’s Audit Committee, the Audit Committee informed the Company and the Company has taken prompt actions in regard to such concerns. An independent inventory count was conducted on April 30, 2024 and the count substantiated the transaction in question.

 

Regardless of the arrangement of the inventory count in order to solve such specific concern, on April 10, 2024, the Chairman of the Company’s Audit Committee was informed that KPMG had suspended all further audit work and, as a result, the Company was unable to timely file its Form 10-K for fiscal year 2023 within the SEC deadlines.

 

(b) Engagement of New Independent Registered Public Accounting Firm

 

On April 29, 2024, RBSM LLP (“RBSM”) was appointed by the Company’s Audit Committee as the Company’s independent registered public accounting firm, to audit the Company’s consolidated financial statements as of and for the fiscal year ended December 31, 2023, subject to customary client acceptance procedures. On May 21, 2024, RBSM completed such procedures, formally accepted its appointment by executing an engagement letter with the Company and issued its independence letter to the Company’s Audit Committee.

 

During the two most recent fiscal years and through May 21, 2024, the Company had not consulted with RBSM regarding any matter that was the subject of a disagreement or a reportable event described in Items 304(a)(1)(iv) or (v), respectively, of Regulation S-K.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

 

(d)  Exhibits.

 

Exhibit No.

 

Exhibit Title or Description

16.1

 

Letter from KPMG to the SEC*

16.2

 

Response Letter from Cosmos Health Inc. to KPMG*

99.1

 

Press Release of Cosmos Health Inc. dated May 24, 2024 and titled “Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q”

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

*Previously filed in Amendment No.1.

 

 
4

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

COSMOS HEALTH INC.

 

Date: May 24, 2024

By:

/s/ Georgios Terzis

Georgios Terzis

 

Chief Financial Officer

 

 
5

 

 EX-99.1 2 cosm_ex991.htm PRESS RELEASE cosm_ex991.htm

 

EXHIBIT 99.1

 

Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q

 

CHICAGO, IL / ACCESSWIRE / May 24, 2024 / Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that on May 21, 2024, it received an additional delinquency letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it continues to be out of compliance with Nasdaq’s continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1) due to the Company’s failure to timely file its Form 10-Q for the period ended March 31, 2024, as well as remaining delinquent in filing its Annual Report on Form 10-K for the period ended December 31, 2023 (the “Initial Delinquent Filing”).

 

In the initial delinquency letter dated April 17, 2024, Nasdaq provided the Company with 60 days, or until June 17, 2024, to submit a definitive plan (the “Plan”) addressing how it intends to regain compliance with Nasdaq’s Listing Rules. If accepted, Nasdaq can grant an extension of up to 180 calendar days from the due date of the Initial Delinquent Filing, or until October 14, 2024, to regain compliance. If Nasdaq does not accept the Company’s Plan, the Company will have the opportunity to appeal that decision to a Hearings Panel.

 

The additional delinquency letter has no immediate effect on the listing of the Company's shares on Nasdaq.

 

Greg Siokas, Chief Executive Officer of Cosmos Health, stated: “We will submit a definitive plan to Nasdaq on a timely basis and proceed to regain compliance.”

 

About Cosmos Health Inc.

 

Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe® and C-Sept®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency, it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com,  www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, as well as LinkedIn and X.

 

 

 

 

Forward-Looking Statements

 

With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could", are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company's ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic and the war in Ukraine, on the Company's business, operations and the economy in general, and the Company's ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's filings with the SEC, which are available at the SEC's website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Investor Relations Contact:

 

BDG Communications

 

cosm@bdgcommunications.com

 

+44 207 0971 653

 

 

2

 

 EX-101.SCH 3 cosm-20240426.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 cosm-20240426_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Amendment Description Entity Emerging Growth Company Document Period End Date Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer EX-101.CAL 5 cosm-20240426_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 cosm-20240426_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 cosm-20240426_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
Apr. 26, 2024
Cover [Abstract]  
Entity Registrant Name Cosmos Health Inc.
Entity Central Index Key 0001474167
Document Type 8-K/A
Amendment Flag true
Amendment Description On April 26, 2024, Cosmos Health Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) to report the dismissal of KPMG Certified Auditors S.A. (“KPMG”) as the Company’s independent registered public accounting firm, effective immediately, and related matters under Item 4.01 of Form 8-K. On May 2, 2024, the Company filed an Amendment on Form 8-K/A (“Amendment No. 1”) to amend the Original Report to include disclosure regarding the appointment of new independent registered auditors of the Company, as required under Item 4.01(b), and to file Exhibit 16.1, Letter from KPMG to the SEC and Exhibit 16.2, Response Letter from Cosmos Health Inc. to KPMG. On May 3, 2024, the Company amended the Original Report by filing a second Amendment on Form 8-K/A (“Amendment No. 2”) regarding the disclosures about the appointment of new independent registered auditors of the Company under Item 4.01(b).
Entity Emerging Growth Company false
Document Period End Date Apr. 26, 2024
Entity File Number 000-54436
Entity Incorporation State Country Code NV
Entity Tax Identification Number 27-0611758
Entity Address Address Line 1 141 West Jackson Blvd
Entity Address Address Line 2 Suite 4236
Entity Address City Or Town Chicago
Entity Address State Or Province IL
Entity Address Postal Zip Code 60604
City Area Code 312
Local Phone Number 865-0026
Security 12b Title Common Stock, $.001 par value
Trading Symbol COSM
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>]9!:G%C:^?VZH:TE[VE-S9 MNMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P9:P!Q+MT MFF6SU%L,9KD8M;:X1+_)UW,#ECQ ,ZE._<]'<')O$8T.,5 MRMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:-Y&:6J6"% M'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_4R-5%1:P MIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!N[RZ .;O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0 ( M !LPO%@D'INBK0 /@! : >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E M;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_ M[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ M0=@S9)[NF:*'3^ 5!+ P04 M " ;,+Q899!YDAD! #/ P $P %M#;VYT96YT7U1Y<&5S72YX;6RM MDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85-K'C> MO,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0 MP1-XJBA[E.O5,[1R;ZEXZ7D;3?!-FI6.5Z*U .EK >MKBRAE#VQH% M.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D M(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S6 M3AI_YHOA/UY_ 5!+ 0(4 Q0 ( !LPO%@'04UB@0 +$ 0 M " 0 !D;V-0&UL4$L! A0#% @ &S"\6*4* M_43O *P( !$ ( !KP &1O8U!R;W!S+V-O&UL M4$L! A0#% @ &S"\6)E&PO=V]R:W-H965T&UL M4$L! A0#% @ &S"\6)^@&_"Q @ X@P T ( !* X M 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! M A0#% @ &S"\6"0>FZ*M ^ $ !H ( !31, 'AL M+U]R96QS+W=O9(9 M 0 SP, !, ( !,A0 %M#;VYT96YT7U1Y<&5S72YX;6Q0 52P4& D "0 ^ @ ?!4 end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 24 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://cosm.com/role/Cover Cover Cover 1 false false All Reports Book All Reports cosm-20240426.xsd cosm-20240426_cal.xml cosm-20240426_def.xml cosm-20240426_lab.xml cosm-20240426_pre.xml cosm_8ka.htm http://xbrl.sec.gov/dei/2023 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cosm_8ka.htm": { "nsprefix": "cosm", "nsuri": "http://cosm.com/20240426", "dts": { "schema": { "local": [ "cosm-20240426.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "cosm-20240426_cal.xml" ] }, "definitionLink": { "local": [ "cosm-20240426_def.xml" ] }, "labelLink": { "local": [ "cosm-20240426_lab.xml" ] }, "presentationLink": { "local": [ "cosm-20240426_pre.xml" ] }, "inline": { "local": [ "cosm_8ka.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://cosm.com/role/Cover", "longName": "000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-04-26to2024-04-26", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "cosm_8ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-04-26to2024-04-26", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "cosm_8ka.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 2", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001477932-24-003315-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-24-003315-xbrl.zip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cosm_8ka_htm.xml IDEA: XBRL DOCUMENT 0001474167 2024-04-26 2024-04-26 iso4217:USD shares iso4217:USD shares 0001474167 true On April 26, 2024, Cosmos Health Inc. (the &#8220;Company&#8221;) filed a Current Report on Form 8-K (the &#8220;Original Report&#8221;) to report the dismissal of KPMG Certified Auditors S.A. (&#8220;KPMG&#8221;) as the Company&#8217;s independent registered public accounting firm, effective immediately, and related matters under Item 4.01 of Form 8-K. On May 2, 2024, the Company filed an Amendment on Form 8-K/A (&#8220;Amendment No. 1&#8221;) to amend the Original Report to include disclosure regarding the appointment of new independent registered auditors of the Company, as required under Item 4.01(b), and to file Exhibit 16.1, Letter from KPMG to the SEC and Exhibit 16.2, Response Letter from Cosmos Health Inc. to KPMG. On May 3, 2024, the Company amended the Original Report by filing a second Amendment on Form 8-K/A (&#8220;Amendment No. 2&#8221;) regarding the disclosures about the appointment of new independent registered auditors of the Company under Item 4.01(b). 8-K/A 2024-04-26 Cosmos Health Inc. NV 000-54436 27-0611758 141 West Jackson Blvd Suite 4236 Chicago IL 60604 312 865-0026 Common Stock, $.001 par value COSM NASDAQ false false false false false